Café

© 2026 Longbridge｜Terms of Service Privacy Policy

SNGX

SNGX

0.40105.50%( +0.0209 )

LongbridgeAI

Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results

Unusual Whales

Aug 7, 2026 at 06:56 AM

Princeton, New Jersey on August 7, 2026 - Soligenix, Inc. (Nasdaq: SNGX), a biopharmaceutical firm specializing in developing and marketing treatments for rare diseases with unmet medical requirements, shared its latest developments.

Source: Unusual Whales The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Soligenix

SNGX.US

Open

--

High

--

Low

--

Prev Close

--

P/E^TTM

--

Market Cap

--